Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival
Titel:
Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival
Auteur:
Eklund, Ella A. Orgard, Mathilda Wallin, Delice Sayin, Sama I. Fagman, Henrik Isaksson, Johan Raghavan, Sukanya Akyürek, Levent M. Nyman, Jan Wiel, Clotilde Hallqvist, Andreas Sayin, Volkan I.